Effects of modality change on health-related quality of life

Hemodialysis International

Volumn 16, Issue 3, 2012, Pages 377-386

  Painter, Patricia ^a   Krasnoff, Joanne B ^b   Kuskowski, Michael ^c   Frassetto, Lynda ^d   Johansen, Kirsten ^d  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Daily dialysis; Dialysis; Quality of life; Transplant

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; HEMOGLOBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DONOR; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE QUALITY OF LIFE INSTRUMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHYSICAL FUNCTIONING AND PHYSICAL COMPOSITE SCALE; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; SHORT FORM 36; UREA NITROGEN BLOOD LEVEL; VITALITY AND GENERAL HEALTH SCALE;

ADULT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS;

EID: 84863433048     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00676.x     Document Type: Article

References (30)

1. Valderrabano F, Jofre R, Lopez-Gomez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis. 2001; 38:443-464.
2. Dew MA, Switzer GE, Goycoolea JM, etal. Does transplantation produce quality of life benefits? Transplantation. 1997; 64:1261-1273.
3. Evans RW, Manninen DL, Garrison LP, etal. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985; 312:553-559.
4. Liem YS, Bosch JL, Arends LR, Heijenbrok-Kal MH, Hunink MGM. Quality of life assessed with the medical outcomes study short form 36-item health survey of patients on renal replacement therapy: A systematic review and meta-analysis. Value Health. 2007; 10:390-397.
5. Kovacs AZ, Molnar MZ, Szeifert L, etal. Sleep disorders, depressive symptoms and health-related quality of life- a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis. Nephrol Dial Transplant. 2011; 26:1058-1065.
6. Punal J, Lema LV, Sanhez-Guisande D, Ruano-Ravina A. Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: A systematic review. Nephrol Dial Transplant. 2008; 23:2634-2646.
7. Kurella M, Suri RS, Chertow GM. Frequent hemodialysis and psychosocial function. Semin Dial. 2005; 18:132-136.
8. The Frequent Hemodialysis Trial Group. In center hemodialysis six times per week versus three times per week. N Engl J Med. 2010; 363:2287-2300.
9. Painter P, Krasnoff JB, Kuskowski M, Frassetto L, Johansen K. Effects of modality change and transplant on peak oxygen uptake in patients with kidney failure. Am J Kidney Dis. 2011; 57:113-122.
10. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription (5th edition). Philadelphia (PA): Williams & Wilkins. 1995.
11. Ibrahim HN, Foley R, Tan L, etal. Long-term consequences of kidney donation. N Engl J Med. 2009; 360:459-469.
12. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the Kidney Disease Quality of Life (KDQOL) instrument. Qual Life Res. 1994; 3:329-338.
13. Glover C, Banks P, Carson A, Martin CR, Duffy T. Understanding and assessing the impact of end-stage renal disease on quality of life. Patient. 2011; 4:19-30.
14. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual (2nd edition). Boston (MA): Health Institute. 1994.
15. Hall YN, Larive B, Painter P, etal. Effects of six versus three times per week hemodialysis on physical performance, health and functioning: Frequent Hemodialysis Network (FHN) randomized trials. J Am Soc Nephrol. 2011 (in press).
16. Samsa G, Edelman D, Rothman ML, etal. Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999; 15:141-155.
17. Hays RD, Farivar SS, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD. 2005; 2:63-67.
18. Cohen J. Statistical Power Analysis for the Behavioral Sciences (revised edition). New York: Academic Press, Inc. 1989.
19. Lopes AA, Bragg-Gresham JL, Goodkin DA, etal. Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res. 2007; 16:545-557.
20. Andre MB, Rembold SM, Pereira CM, Lugon JR. Prospective evaluation of an in-center daily hemodialysis program: Results of two years of treatment. Am J Nephrol. 2002; 22:473-479.
21. Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in The Netherlands: Effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant. 1998; 13:2853-2869.
22. Williams AW, Chebrolu SB, Ing TS, etal. Early clinical, quality of life, and biochemical changes of "daily hemodialysis" (6 dialyses per week). Am J Kidney Dis. 2004; 43:90-102.
23. Heidenheim AP, Muirhead N, Moist L, et al. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis. 2003; 42:36-41.
24. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003; 42:1020-1035.
25. Rosenberger J, Vandijk JP, Prihodova I, et al. Differences in perceived health status between kidney transplant recipients and dialyzed patients are based mainly on the selection process. Clin Transplant 2006; 24:358-365.
26. Macfarlane PA. Should patients remain on intensive hemodialysis rather than choosing to receive a kidney transplant? Semin Dial. 2010; 23:516-519.
27. Deoreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization and dialysis-attendance compliance. Am J Kidney Dis. 1997; 30:204-212.
28. Knight E, Ofsthun N, Teng M, Lazarus JM, Curhan GC. The association between mental health, physical function and hemodialysis mortality. Kidney Int. 2003; 63:1843-1851.
29. Mapes DL, Lopes AA, Satayathum S, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis outcomes and practice patterns study (DOPPS). Kidney Int. 2003; 64:339-349.
30. Parkerson GR, Gutman RA. Health-related quality of life predictors of survival and hospital utilization. Health Care Financ Rev. 2001; 21:171-184.